Future challenges for health economics and health technology assessment of biological drugs.
Gulácsi
László
L
D001688:Biological Products / Q000191:economics* / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D006801:Humans; D015994:Incidence; D010349:Patient Compliance; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D012216:Rheumatic Diseases / Q000188:drug therapy; D013673:Technology Assessment, Biomedical
D001688:Biological Products
Eur J Health Econ. 2010 Jan;10 Suppl 1:S35-40
20012135
Eur J Health Econ. 2008 Jan;8 Suppl 2:95-106
18157559
Semin Arthritis Rheum. 2009 Apr;38(5):396-402
18336875
Eur J Health Econ. 2008 Jan;8 Suppl 2:S49-60
18157732
Eur J Health Econ. 2006 Dec;7(4):223-4
17077979
Int J Technol Assess Health Care. 2004 Summer;20(3):337-41
15446763
Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:120-6
19500441